go to main content
Research Departments Health Evidence News
News items related to the Department of Health Evidence.
Results (58)

Filter results

Epidemiology and reporting characteristics of preclinical systematic reviews in PLoS Biology

7 June 2021

Kim Wever, researcher of the department of Health Evidence and an international team published the article 'Epidemiology and reporting characteristics of preclinical systematic reviews' in PLoS Biology.

Millions of euros for study of laser treatment for glioblastoma

2 April 2021

A research group from Radboudumc and UMC Utrecht is to investigate laser treatment of a rare brain tumor, glioblastoma. 3.9 million euros has been made available for the research by Zorginstituut Nederland and ZonMw, under the auspices of the Subsidy Scheme for Promising Care.

Mireille Broeders appointed full Professor of Personalized Cancer Screening

18 June 2020

Mireille Broeders of the Department for Health Evidence has been appointed full professor of Personalized Cancer Screening. This appointment became effective on 1 May 2020.

Differences in the placental disposition of TNF inhibitors uncovered

19 March 2020

In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept.

Plugging the gap ZonMw/Health Holland grant

3 March 2020

RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM).

Citizen forum on coverage decisions in the Dutch health insurance benefit package

3 February 2020

In this article published in Value in Health RIHS researchers Leon Bijlmakers, Maarten Jansen and Rob Baltussen describe the preferences and dilemmas expressed by Dutch citizens in eight case studies, all of which require trade-offs between criteria that cannot all be satisfied at the same time.

The PRIDE Study Evaluation of online methods of data collection

16 January 2020

In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.

Awarded KWF grants for Radboudumc researchers

18 December 2019

KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work.

Merel Ritskes-Hoitinga has been appointed honorary Skou professor at Aarhus University

17 October 2019

Merel Ritskes-Hoitinga has been appointed honorary Skou Professor at the Dept. of Clinical Medicine, at Aarhus University. The aim is to introduce new perspectives to teaching, strengthen relations with leading research units abroad and establish joint research projects and funding applications.

Kit Roes appointed Professor of Biostatistics

9 September 2019

Roes' research mainly concentrates on innovative designs and the analysis of clinical research for rare disorders, a focus that fits well with the more individual patient-oriented treatment.

Social media posts on medication use during pregnancy often incorrect

23 August 2019

Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.

European Commission Initiative on Breast Cancer (ECIBC) Guidelines

13 August 2019

In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer.

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019

With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success.

Wija Oortwijn elected vice-president Health Technology Assessment international

6 June 2019

Wija Oortwijn has been elected vice-president of Health Technology Assessment international (HTAi) for the period 2019-2021.

Ingenious solution, but what was the problem?

29 May 2019

In Value in Health Anouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt and Janneke Grutters found, using a mixed methods approach, that although a recently developed medical technology was deemed ingenious by stakeholders, there was no underlying problem it could solve in its intended context.

How do we keep new technology affordable to improve the lives of people?

16 May 2019

Improving healthcare by means of new technological developments? We need to change the entire approach for evaluating the true impact , says Maroeska Rovers. By bringing together all stakeholders from the beginning, millions of euros can be saved.

Association of gestational weight gain with adverse maternal and infant outcomes

13 May 2019

An individual participant meta-analysis published in JAMA showed that pregnancy BMI is related stronger to maternal and infant complications than to gestational weight gain. The PRIDE Study, with coauthors Marleen van Gelder and Nel Roeleveld, was one of the participating cohorts.

Blog: Species Differences The Elephant in the Room

17 January 2019

Read the blog of Merel Ritskes-Hoitinga in the New England anti-vivisection society (neavs) based on a paper published in the Journal of Translational Medicine.

Research into drugs for treating rare diseases can be more efficient and patient-oriented

18 December 2018

To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).

Bart Kiemeney among most cited researchers

13 December 2018

Bart Kiemeney made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.

Eddy Adang reappointed as member Health Council

21 November 2018

The Health Council of the Netherlands is an independent scientific advisory body whose legal task it is to advise ministers and Parliament in the field of public health and health/healthcare research.

Science for Disaster Risk Management 2020

21 November 2018

Paul Scheepers has been invited as contributing author to the flagship Report “Science for Disaster Risk Management 2020 -  Acting today, Protecting Tomorrow”.

Beyond the scientist: Ellen van Jaarsveld

21 November 2018

Ellen is assistant Professor at the Department for Health Evidence and at the Department of Primary and Community Care, thanks Jamie for inspiring her husband to cook delicious family meals.

TURBO grants for four medical-technical research projects

8 November 2018

Four TURBO grants were awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between Radboudumc and the University of Twente.

Merel Ritskes-Hoitinga appointed Honorary Skou Professor at Aarhus University

6 November 2018

With the title Aarhus University wishes to honour the internationally highly esteemed research and to foster closer ties between our two universities, which are both a member of the Guild.

SYRCLE formal member of the ESI Board

24 October 2018

Merel Ritskes-Hoitinga will be SYRCLE's representative on the Board of Directors of Evidence Synthesis International (ESI)

Identification of dozens of ovarian cancer genes

21 August 2018

In Cancer Research, a global consortium in which Leon Massuger and Bart Kiemeney participate describes the identification of dozens of low-penetrance genes at genomic loci that were previously associated with ovarian cancer.

Merel Ritskes member of the 3RCC Scientific Advisory Board

8 August 2018

The 3RCC Scientific Advisory Board is responsible for providing scientific expertise to the 3RCC, evaluating grant applications and evaluating the progress and functioning of the center.

Personalised risk-based breast cancer screening and primary prevention

5 July 2018

Linda Rainey, Mireille Broeders, Daniëlle van der Waal, and colleagues published three papers last month on the future implementation of risk-based breast cancer screening and prevention.

Making choices in healthcare is difficult but citizens will show politics the way

22 June 2018

Well-informed citizens are not just aware of the financial necessity of making choices in healthcare, they are also prepared to make these choices. They do so by providing concrete criteria and examples, which serve as guidelines for politicians.

Teacher of the year award Scott Maurits

14 June 2018

Last Friday (8 June), Scott Maurits won the Teacher of the Year award for the second year of the bachelor biomedical sciences.

Presentation of Manifesto citizen forum Choices in healthcare

14 June 2018

Which treatments, according to Dutch citizens, should be covered in the health insurance package? And on the basis of which arguments?

Sita Vermeulen appointed associate professor Genetic epidemiology

2 May 2018

Sita's research is embedded within research theme Urological Cancers and focuses on the genetics of bladder cancer.

RIHS blog: Personalized and innovative – what was the question again?

25 April 2018

Blog by Anouck Kluytmans, researcher in early health technology assessment methodology at the Department for Health Evidence.

Shorter-term provision of antibiotics in Lyme disease is cost-effective

25 April 2018

In a PLOS One publication Eddy Adang, Anneleen Berende en Bart Jan Kullberg, showed that shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease is cost-effective.

The National Healthcare Institute (ZIN) provides insight in the displacement of healthcare

25 April 2018

Displacement of care is difficult to assess. On behalf of the National Healthcare Institute, a consortium led by the Radboudumc has therefore carried out research into displacement of care in Dutch healthcare.

Dead should be 0 in models combining survival and quality of life

18 April 2018

This result found by Bram Roudijk and colleagues, was published in Medical Decision Making.

Radboudumc Masterprijs Biomedical Sciences 2016-2017 for Martijn Simons

4 April 2018

Title master internship: The influence of a risk-based follow-up on the early detection of recurrences in patients treated for oropharyngeal cancer

Results of Q fever research widespread in the media

22 March 2018

Algemeen Dagblad, Brabants Dagblad, De Gelderlander, NOS, Radio 1, Hart van Nederland and EenVandaag paid attention to the research results concerning the long-term effects of Q fever.

Vici grant for Maroeska Rovers

23 February 2018

Maroeska Rovers, Professor of Evidence Based Surgery, will receive a Vici research grant of 1.5 million euros from NWO (Netherlands Organisation for Scientific Research).

First lustrum student visit WHO & UNAIDS in Geneva

7 February 2018

The students got a firsthand experience of what it is like to be in the Global Health capital of the world, to get a better understanding of the broader context of global health policy and the implementation of international health guidelines.

Eddy Adang has been elected to the UMC Council

6 February 2018

Eddy Adang has been elected to the UMC Council and will formally join on 1 March 2018.

Apply for the Cochrane-REWARD prize for reducing waste in research

31 January 2018

Deadline for nominations 15 May.

Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies

31 January 2018

In PLoS ONE Carlijn Hooijmans and colleagues describe how the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, could be used to rate the certainty in the evidence of preclinical animal studies in the context of therapeutic interventions.

Improving the conduct, reporting and appraisal for animal research

16 January 2018

SYRCLE (Merel Ritskes-Hoitinga and Kim Wever) has published an invited Editorial in the British Medical Journal

KWF research grant for Alina Vrieling

8 January 2018

Lifestyle habits and bladder cancer prognosis: effects by tumour stage and molecular subtype.

A Western diet increases risk of recurrence in bladder cancer

21 December 2017

Alina Vrieling and Ellen Westhoff, theme Urological cancers, recently published in the International Journal of Cancer about the influence of dietary factors on urinary bladder cancer prognosis.

Citizen panel on making choices in health care

23 November 2017

The citizen panel on making choices in health care (burgerforum ‘keuzes in de zorg’) was initiated by the section HTA of the Department for Health Evidence. The latest newsletter is available.

Ten new members for Academia Europaea

15 September 2017

Ten Radboud professors have been appointed to the Academia Europaea, the European association of scientists who are among the best in the world.

NWO Vidi grant for Sita Vermeulen

10 August 2017

For her project: Personalizing BCG immunotherapy in bladder cancer: a novel approach using germline and acquired DNA variants

  • Wapen van Radboudumc